Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | DHODH | Q02127 | 1/20 | 0.49 |
| ▸ | FADS1 | O60427 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14853314 | 0.83 | HDAC1 (0.61) | MAPTKMT2AMEN1RAB9AALDH1A1 | |
| SCHEMBL28045650 | 0.78 | ALDH1A1 (0.56) | MAPTKMT2AMEN1RAB9AALDH1A1 | |
| SCHEMBL11306381 | 0.78 | TACR1 (0.63) | MAPTKMT2AMEN1ALDH1A1TP53 | |
| SCHEMBL14546948 | 0.77 | LNPEP (0.51) | MAPTKMT2AMEN1RAB9ANPSR1 | |
| SCHEMBL2610069 | 0.75 | KMT2A (0.54) | KMT2AMEN1RAB9AALDH1A1GAA | |
| SCHEMBL9724967 | 0.75 | MAPT (0.67) | MAPTKMT2AMEN1RAB9AALDH1A1 | |
| SCHEMBL7354597 | 0.74 | NPY5R (0.56) | MMP8 | |
| SCHEMBL2685172 | 0.74 | HDAC8 (0.46) | MAPTKMT2AMEN1RAB9ATP53 | |
| SCHEMBL9724978 | 0.74 | KMT2A (0.52) | MAPTKMT2AMEN1RAB9AALDH1A1 | |
| SCHEMBL28556648 | 0.74 | MAPT (0.65) | MAPTKMT2AMEN1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230330061-A1 | ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2023-10-19 | — | — | US | disclosed |
| US-20230330061-A1 | ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2023-10-19 | — | — | US | disclosed |
| EP-4260704-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING A PHENYL UREA COMPOUND AND A CIS-UNSATURATED FATTY ACID WITH 16 TO 22 CARBON ATOMS | National Taiwan University (TW) | 2023-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230330061-A1 | ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | FASN, NAAA, FPR3 | MAPT 1959/4885KMT2A 3625/4885MEN1 4453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.